At the time of writing, Macerich Co [MAC] stock is trading at $17.71, up 3.81%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MAC shares have gain 1.78% over the last week, with a monthly amount drifted -0.45%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Macerich Co [NYSE: MAC] stock has seen the most recent analyst activity on January 15, 2025, when Morgan Stanley upgraded its rating to a Equal-Weight but kept the price target unchanged to $20 for it. Previously, Jefferies upgraded its rating to Buy on January 02, 2025, and elevated its price target to $23. On December 17, 2024, upgrade upgraded it’s rating to Sector Perform but maintained its price target of $22 on the stock. Deutsche Bank started tracking the stock assigning a Hold rating and suggested a price target of $22 on December 17, 2024. Mizuho upgraded its rating to a Neutral and raised its price target to $22 on December 04, 2024. Scotiabank downgraded its rating to Sector Underperform for this stock on May 17, 2024, and downed its price target to $14. In a note dated May 01, 2024, Piper Sandler downgraded an Underweight rating on this stock and revised its target price from $17 to $11.
For the past year, the stock price of Macerich Co fluctuated between $12.60 and $22.27. Currently, Wall Street analysts expect the stock to reach $20 within the next 12 months. Macerich Co [NYSE: MAC] shares were valued at $17.71 at the most recent close of the market. An investor can expect a potential return of 12.93% based on the average MAC price forecast.
Analyzing the MAC fundamentals
According to Macerich Co [NYSE:MAC], the company’s sales were 924.36M for trailing twelve months, which represents an 15.72% jump. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at 0.33%, Pretax Profit Margin comes in at -0.5%, and Net Profit Margin reading is -0.21%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.08 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.84.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.99 points at the first support level, and at 16.28 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.18, and for the 2nd resistance point, it is at 18.66.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 5.03, the price to book ratio is 1.63.
Transactions by insiders
Recent insider trading involved Murphy Devin Ignatius, Director, that happened on Mar 14 ’25 when 7000.0 shares were purchased. President and CEO, Hsieh Jackson completed a deal on Mar 04 ’25 to buy 56000.0 shares. Meanwhile, Director Stephen Andrea M sold 63289.0 shares on Dec 26 ’24.
